Literature DB >> 11856157

Limitations of the Gail model in the specialized breast cancer risk assessment clinic.

David M Euhus1, A Marilyn Leitch, James F Huth, George N Peters.   

Abstract

The Gail model is a risk assessment tool that is accurate for general breast cancer risk screening. Because of the limited way that this model incorporates family history information, however, there are concerns that it may underestimate risk for many women attending specialized breast cancer risk assessment clinics. We collected comprehensive breast cancer risk factor information for 213 women attending a specialized breast cancer risk assessment clinic using a modified version of the CancerGene software. Breast cancer risk was calculated using the models of Gail and Claus as well as BRCAPRO and the tables of Bodian (for women with lobular neoplasia). Eighty-six percent of the women had a family history of breast cancer. Although 74% of women had risk factor histories that are thought to confound the Gail model (family history of breast cancer in second-degree relatives, family history of breast cancer before the age of 50, family history of bilateral breast cancer, family history of ovarian cancer, or personal history of lobular neoplasia), the inclusion of other models increased the risk level assignment in only 13% of the cases. We conclude that the Gail model is an appropriate risk assessment tool for most women attending specialized clinics, although the inclusion of models better able to account for family history information and personal history of lobular neoplasia is required to accommodate all women.

Entities:  

Mesh:

Year:  2002        PMID: 11856157     DOI: 10.1046/j.1524-4741.2002.08005.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  17 in total

1.  Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.

Authors:  Norbert W Paul; Mita Banerjee; Susanne Michl
Journal:  J Community Genet       Date:  2013-11-08

2.  Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.

Authors:  Sandhya Pruthi; Li Yang; Nicole P Sandhu; James N Ingle; Cheryl L Beseler; Vera J Suman; Ercole L Cavalieri; Eleanor G Rogan
Journal:  J Steroid Biochem Mol Biol       Date:  2012-02-24       Impact factor: 4.292

Review 3.  Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Authors:  Sandhya Pruthi; Bobbie S Gostout; Noralane M Lindor
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

4.  Belief in numbers: When and why women disbelieve tailored breast cancer risk statistics.

Authors:  Laura D Scherer; Peter A Ubel; Jennifer McClure; Sarah M Greene; Sharon Hensley Alford; Lisa Holtzman; Nicole Exe; Angela Fagerlin
Journal:  Patient Educ Couns       Date:  2013-04-24

5.  Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening.

Authors:  Barry I Graubard; Andrew N Freedman; Mitchell H Gail
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-14       Impact factor: 4.254

6.  Cancer genetics service interest in women with a limited family history of breast cancer.

Authors:  Tamara J Somers; Julie C Michael; William M P Klein; Andrew Baum
Journal:  J Genet Couns       Date:  2009-05-14       Impact factor: 2.537

7.  Assessing and managing breast cancer risk: clinical tools for advising patients.

Authors:  Bernard Friedenson
Journal:  MedGenMed       Date:  2004-01-14

8.  Gail model risk assessment and risk perceptions.

Authors:  John M Quillin; Elizabeth Fries; Donna McClish; Ellen Shaw de Paredes; Joann Bodurtha
Journal:  J Behav Med       Date:  2004-04

9.  Breast cancer risk assessment in socioeconomically disadvantaged urban communities.

Authors:  Chyongchiou Jeng Lin; Bruce Block; Mary Patricia Nowalk; Mattie Woods; Edmund M Ricci; Keith H Morgenlander; Dwight E Heron
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

10.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

Authors:  E Amir; D G Evans; A Shenton; F Lalloo; A Moran; C Boggis; M Wilson; A Howell
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.